» Articles » PMID: 31371999

LncRNA LINC00668 Promotes the Progression of Breast Cancer by Inhibiting Apoptosis and Accelerating Cell Cycle

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2019 Aug 3
PMID 31371999
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

To elucidate how lncRNA 00668 (LINC00668) influences the development of breast cancer (BC). Genome-wide expression profile of BC and paracancerous tissues were downloaded from The Cancer Genome Atlas (TCGA) and BC tissues and paracancerous tissues enrolled from our hospital for analyzing the expression level of LINC00668 and its correlation with prognosis. GSEA was conducted to analyze the potential functions of LINC00668. By transfection of sh-LINC00668 in BC cells, proliferation, apoptosis, cell cycle and colony formation of BC cells were accessed. Western blot was conducted to detect protein expressions of Ki-67, CDK4, Bcl-2, p21 and genes in AKT/mTOR pathways after LINC00668 knockdown in BC cells. Finally, tumor-bearing nude mice were administrated with BC cells. We compared the proliferative rate in mice with different administrations. Immunohistochemistry was carried out to access expression levels of Ki-67, CDK4, Bcl-2 and P21 in mice. Both TCGA data and BC tissues harvested from our hospital indicated the higher expression of LINC00668 in BC tissues. LINC00668 expression was negatively correlated to prognosis of BC patients. GSEA pointed out that LINC00668 is enriched in regulations of cell cycle and apoptosis. By transfection of sh-LINC00668 in MDA-MB-231 and MDA-MB-436 cells, the proliferative and colony formation abilities of BC cells decreased. Besides, LINC00668 knockdown in BC cells induced apoptosis and arrested cell cycle. LINC00668 knockdown downregulated Ki-67, CDK4 and Bcl-2, but upregulated p21. The AKT/mTOR pathway was inhibited after LINC00668 silenced. In vivo experiments demonstrated the decreased proliferative rate in tumor-bearing mice administrated with sh-LINC00668 transfected BC cells. Consistently, immunohistochemical results showed lower positive expressions of Ki-67, CDK4 and Bcl-2, but higher positive expression of p21 in sh-LINC00668 group. LINC00668 is highly expressed in BC tissues and can promote the progression of BC by inhibiting apoptosis and accelerating cell cycle progression.

Citing Articles

Long Intergenic Non-Coding RNAs of Human Chromosome 18: Focus on Cancers.

Ershov P, Yablokov E, Mezentsev Y, Ivanov A Biomedicines. 2024; 12(3).

PMID: 38540157 PMC: 10968066. DOI: 10.3390/biomedicines12030544.


Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer.

Chen H, Xie G, Luo Q, Yang Y, Hu S Funct Integr Genomics. 2023; 23(3):233.

PMID: 37432486 DOI: 10.1007/s10142-023-01130-z.


Long Non-Coding RNAs, Cell Cycle, and Human Breast Cancer.

Yin Q, Ma H, Bamunuarachchi G, Zheng X, Ma Y Hum Gene Ther. 2023; 34(11-12):481-494.

PMID: 37243445 PMC: 10398747. DOI: 10.1089/hum.2023.074.


Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis.

Zangouei A, Zangoue M, Taghehchian N, Zangooie A, Rahimi H, Saburi E Biol Res. 2023; 56(1):1.

PMID: 36597150 PMC: 9808980. DOI: 10.1186/s40659-022-00411-4.


LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway.

Chen W, Liu Y, Kang S, Lv X, Fu W, Zhang J Oxid Med Cell Longev. 2022; 2022:5215748.

PMID: 35799892 PMC: 9256459. DOI: 10.1155/2022/5215748.


References
1.
Evan G, Vousden K . Proliferation, cell cycle and apoptosis in cancer. Nature. 2001; 411(6835):342-8. DOI: 10.1038/35077213. View

2.
Bearss D, Lee R, Troyer D, Pestell R, Windle J . Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties. Cancer Res. 2002; 62(7):2077-84. View

3.
Normile D . Cell proliferation. Common control for cancer, stem cells. Science. 2002; 298(5600):1869. DOI: 10.1126/science.298.5600.1869. View

4.
Liang J, Slingerland J . Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle. 2003; 2(4):339-45. View

5.
Mincey B . Genetics and the management of women at high risk for breast cancer. Oncologist. 2003; 8(5):466-73. DOI: 10.1634/theoncologist.8-5-466. View